Clinical Notes: Cause of Death Often False - MedPage Today MedPage Today Enzastaurin is a serine-threonine kinase inhibitor that inhibits tumor angiogenesis by targeting protein kinase C-beta and the PI3K/AKT pathway. The lymphoma trial had enrolled patients at high risk of relapse after chemotherapy including rituximab ... |
